Healthcare > Medical Devices & Equipment
•1091 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1091)
| Company | Market Cap | Price |
|---|---|---|
|
STAA
STAAR Surgical Company
STAAR directly manufactures ophthalmic medical devices, primarily implantable lenses (EVO ICL) used for vision correction.
|
$1.25B |
$25.10
+1.95%
|
|
EYPT
EyePoint Pharmaceuticals, Inc.
Implantable ophthalmic device component due to bioerodible Durasert E delivery system.
|
$1.24B |
$14.96
+1.01%
|
|
CNMD
CONMED Corporation
A large share of revenues comes from single-use disposable medical device products, i.e., consumables.
|
$1.21B |
$39.09
+3.11%
|
|
IRMD
IRadimed Corporation
IRADIMED's core offerings are MRI-compatible medical devices (infusion pumps and monitoring systems), which fall under Medical Devices & Biometrics.
|
$1.19B |
$93.47
+1.73%
|
|
AZTA
Azenta, Inc.
Azenta's automated sample storage and cryogenic systems fall under Medical Devices & Biometrics.
|
$1.15B |
$25.04
+2.96%
|
|
AVNS
Avanos Medical, Inc.
The RFA portfolio (ESENTEC, TRIDENT, COOLIEF) places Avanos in the neuromodulation devices category.
|
$1.14B |
$24.63
-0.12%
|
|
SPRY
ARS Pharmaceuticals, Inc.
Neffy includes a needle-free delivery device, aligning with Medical Devices & Biometrics.
|
$1.10B |
$11.36
+1.88%
|
|
CDNA
CareDx, Inc
Directly provides Laboratory Testing & Advisory Services through its testing portfolio and diagnostic operations.
|
$1.10B |
$21.40
-4.55%
|
|
NEO
NeoGenomics, Inc.
They provide comprehensive laboratory testing services and advisory support for oncology diagnostics.
|
$1.08B |
$8.37
+2.57%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera is a medical device product, placing Pacira in the Medical Devices & Biometrics category.
|
$1.06B |
$24.75
+3.73%
|
|
XERS
Xeris Biopharma Holdings, Inc.
Prefillable Syringes describe a major packaging format used for injectable drugs in Xeris's portfolio.
|
$1.06B |
$6.38
+4.17%
|
|
AMPH
Amphastar Pharmaceuticals, Inc.
Inhalation systems and advanced formulations imply medical device components bridging drug delivery.
|
$1.05B |
$22.84
+4.72%
|
|
TIC
TIC Solutions, Inc.
Laboratory Testing & Advisory Services aligns with Acuren's lab-based destructive testing capabilities and analytical advisory work.
|
$1.04B |
$8.51
+6.51%
|
|
BLFS
BioLife Solutions, Inc.
Sells consumables such as hPL, CellSeal vials, and CryoCase used within CGT workflows.
|
$1.04B |
$21.50
+3.12%
|
|
OPK
OPKO Health, Inc.
OPKO's BioReference segment provides laboratory testing and advisory services.
|
$951.95M |
$1.23
+1.65%
|
|
SSII
SS Innovations International, Inc.
Core product: robotic surgical system and endo-surgical instruments (SSi Mantra and related tools) sold as surgical equipment.
|
$946.81M |
$4.92
-0.20%
|
|
INMD
InMode Ltd.
InMode's core business is medical devices and biometrics, with RF-based aesthetic platforms and related systems.
|
$926.64M |
$14.65
+2.23%
|
|
THRM
Gentherm Incorporated
Medical devices & biometrics including patient temperature management devices.
|
$908.73M |
$29.76
+4.57%
|
|
BVS
Bioventus Inc.
Bioventus designs and manufactures medical devices and biometrics solutions for musculoskeletal health.
|
$870.67M |
$10.51
+0.96%
|
|
IART
Integra LifeSciences Holdings Corporation
Direct neurosurgery devices and surgical implants (e.g., CerebroFlo EVD catheter, Aurora Surgiscope) are core products.
|
$867.72M |
$11.14
+2.77%
|
|
MRVI
Maravai LifeSciences Holdings, Inc.
Biologics safety testing kits and related analytical services (e.g., residual DNA quantification, Protein L assays) are direct BST offerings.
|
$866.85M |
$3.39
-0.59%
|
|
QDEL
QuidelOrtho Corporation
QuidelOrtho directly develops diagnostic instruments and platforms (including molecular diagnostics platforms) used in labs, aligning with Diagnostic Equipment.
|
$863.41M |
$12.69
|
|
MATW
Matthews International Corporation
Memorialization segment includes embalming chemicals and funeral supplies (memorialization products).
|
$848.12M |
$27.54
+2.23%
|
|
CBLL
CeriBell, Inc.
Ceribell's core product is a point-of-care diagnostic EEG system (diagnostic equipment).
|
$786.06M |
$21.18
+2.12%
|
|
CLB
Core Laboratories N.V.
CLB provides laboratory testing and advisory services via proprietary tracers and reservoir analysis capabilities.
|
$768.30M |
$16.51
-2.42%
|
|
MEG
Montrose Environmental Group, Inc.
Laboratory testing and advisory services as part of Montrose's measurement and analysis offerings.
|
$764.35M |
$21.61
+3.50%
|
|
NUTX
Nutex Health, Inc.
Nutex Health operates micro-hospitals and provides hospital services including acute inpatient care and emergency/observation services.
|
$746.65M |
$105.59
+3.76%
|
|
CSTL
Castle Biosciences, Inc.
Provides laboratory-based molecular diagnostic testing and related advisory services directly to clinicians.
|
$731.18M |
$25.05
+2.00%
|
|
DBVT
DBV Technologies S.A.
Viaskin patch is a medical device delivering therapy; categorize under Medical Devices & Biometrics.
|
$721.78M |
$21.34
+3.54%
|
|
VPG
Vishay Precision Group, Inc.
Medical infusion pump design win indicates participation in the Medical Devices & Biometrics market.
|
$706.71M |
$53.09
+3.34%
|
|
KE
Kimball Electronics, Inc.
KE's medical device and biometrics manufacturing capabilities are central to its strategy.
|
$652.51M |
$26.83
+1.48%
|
|
SRDX
Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
|
$614.58M |
$42.98
|
|
SIBN
SI-BONE, Inc.
SI-BONE operates as a medical device company that designs, develops and sells orthopedic implants and related medical devices.
|
$611.38M |
$14.11
+3.22%
|
|
PSNL
Personalis, Inc.
NeXT Personal is a tumor-informed liquid biopsy-based MRD test, central to PSNL's offerings.
|
$597.65M |
$6.72
+0.90%
|
|
BWAY
BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
|
$597.46M |
$15.85
+3.39%
|
|
CTKB
Cytek Biosciences, Inc.
Cytek's instrument manufacturing includes flow cytometry diagnostic equipment, the core product line referenced in the article.
|
$589.46M |
$4.61
|
|
CRMD
CorMedix Inc.
DefenCath is an FDA-approved antimicrobial catheter-lock device marketed by CorMedix.
|
$582.25M |
$7.39
+3.65%
|
|
TCMD
Tactile Systems Technology, Inc.
Core medical devices for lymphedema and airway clearance (Flexitouch Plus, Nimbl, AffloVest) are manufactured and sold by the company.
|
$574.69M |
$25.72
+2.35%
|
|
EMBC
Embecta Corp.
Embecta operates as a medical device company focused on insulin injection devices, including pen needles, syringes, and safety products.
|
$572.26M |
$9.80
+3.05%
|
|
BBNX
Beta Bionics, Inc.
Core product is a medical device (iLet Bionic Pancreas) and related biometrics in diabetes care.
|
$571.44M |
$12.99
+6.69%
|
|
MLAB
Mesa Laboratories, Inc.
Clinical Genomics hardware (MassARRAY) is diagnostic equipment used in regulated lab environments, fitting Diagnostic Equipment.
|
$569.13M |
$103.28
+4.59%
|
|
MG
Mistras Group, Inc.
MG provides Laboratory Testing & Advisory Services as part of its inspection and testing offerings.
|
$563.13M |
$17.82
+3.66%
|
|
KOPN
Kopin Corporation
CR3 medical headset and defense medical imaging/biometric sensing align with Medical Devices & Biometrics.
|
$543.89M |
$2.98
+1.19%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$539.25M |
$16.20
+4.62%
|
|
ZIMV
ZimVie Inc.
Prosthetics & Implants—core product line includes dental implants and related prosthetic solutions.
|
$530.23M |
$18.99
|
Showing page 5 of 11 (1091 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
